The synergistic effect of stereotactic radiotherapy in conjunction with PD-1 inhibitors has been proven in Merkel cell carcinoma but is still under study as a treatment modality in patients with cuSCC and BCC [91]. The gene discussed is PDCD1; the disease is Merkel cell skin cancer.